top of page
Insights
Views from the Havilland partnership on healthcare investment, market transition, and the companies building the infrastructure of the next era.
MATT HANCOCK
Healthcare has reinvented itself twice in modern history, and each time the biggest returns went not to clinical innovators but to the companies that built the underlying infrastructure. The third transition is happening now.
SHAMIK PAREKH
Europe should own healthcare innovation. It has world-class clinical science, the strongest evidence culture in medicine, structured health data at population scale, and technical founders pouring out of the deepest public-research base anywhere.
URI ADONI
Why This Is the Best Time in a Decade to Invest in Category-Defining Health-Tech Companies
Latest Thinking
MATT HANCOCK
The Great Rewiring
Healthcare has reinvented itself twice in modern history, and each time the biggest returns went not to clinical innovators but to the companies that built the underlying infrastructure. The third transition is happening now.
SHAMIK PAREKH
The European Paradox
Europe should own healthcare innovation. It has world-class clinical science, the strongest evidence culture in medicine, structured health data at population scale, and technical founders pouring out of the deepest public-research base anywhere.
URI ADONI
Why This Is the Best Time in a Decade to Invest in Category-Defining Health-Tech Companies
bottom of page